Preface -- Acknowledgments -- Contents -- Contributors -- 1 Pharmacogenetics of Breast Cancer: Toward the Individualization of Therapy -- 2 Pharmacology, Pharmacogenetics, and Pharmacoepidemiology: Three P's of Individualized Therapy -- 3 Role of Genetic Variability in Breast Cancer Treatment Outcomes -- 4 The Role of Epigenetics in Breast Cancer: Implications for Diagnosis, Prognosis, and Treatment -- 5 Comparative Genomic Hybridization and Copy Number Abnormalities in Breast Cancer -- 6 Gene Expression Profiling as an Emerging Diagnostic Tool to Personalize Chemotherapy Selection for Early Stage Breast Cancer -- 7 Gene Expression-Based Predictors of Prognosis and Response to Chemotherapy in Breast Cancer -- 8 Utilization of Genomic Signatures for Personalized Treatment of Breast Cancer -- 9 Personalized Medicine by the Use of Microarray Gene Expression Profiling -- 10 Predictive Markers for Targeted Breast Cancer Treatment -- 11 Circulating Tumor Cells in Individualizing Breast Cancer Therapy -- 12 Individualization of Endocrine Therapy in Breast Cancer -- 13 TAILORx: Rationale for the Study Design -- 14 Taking Prognostic Signatures to the Clinic -- 15 Tissue is the Issue -- 16 Acquisition and Preservation of Tissue for Microarray Analysis -- 17 Tapping into the Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Gold Mine for Individualization of Breast Cancer Treatment -- 18 Breast Cancer Stem Cells and Their Niche: Lethal Seeds in Lethal Soil -- 19 Molecular Imaging in Individualized Cancer Management -- 20 Cancer Nanotechnology for Molecular Profiling and Individualized Therapy -- Index.